International Meeting on Nucleic Acid Vaccines

Nicholas Mellor ecs at venus.co.uk
Thu Jan 25 23:37:23 EST 1996


Announcement:
Due to various local difficulties, this conference has not received as
wide
publicity as its subject warrants.  Hence this late announcement.

Title:           International Meeting on Nucleic Acid Vaccines
                    for The Prevention of Infectious Diseases

Location:   Natcher Conference Center, Bethesda, Maryland, USA

Dates:       5 - 7 February 1996

Subject: A review of scientific advances in immunology, vaccinology,
work on
primates, vaccine safety assessment, and other areas relevant to the
development of nucleic acid vaccines.

Target Audience: Industry, regulatory and research organisations

Registration Info:  ECS web-site http://www.venus.co.uk/ecs/summary.html

Organiser: TASCOM Inc., Bethesda MA, USA   Telephone: (301) 907-3844

Sponsors: European Commission
          Food & Drug Administration
          National Institute of Allergy and Infectious Diseases
          World Health Organisation

Full Program:
                      Monday, February 5, 1996

    9:00- 9:15   Opening
                 Representatives from the World Health Organization
                 and the
                 National Institutes of Health
    9:15- 9:25   Overview
                 Dr. H. Robinson, University of Massachusetts, USA

                 BASIC IMMUNOLOGY

                 Chairperson: Dr. E. Shevach, National Institutes of
Health,USA

                 1. Mechanisms of Action of Nucleic Acid Vaccines,
                 Target Cell(s), & Antigen Presentation

    9:25 - 9:45  Dr. M. Barry, University of Texas, USA  
  10:05 - 10:40  Break and                     
                 Setting-up of Posters
  10:40 - 11:00  Dr. E. Raz, University of California at San Diego, USA

                 2. Modulation of the Immune Responses to Nucleic Acid
                    Vaccines

   11:00 - 11:20 Dr. I. Ramshaw, Australia National University,
Australia

                 3. Mucosal Immunity

   11:20 - 11:40 Dr. E. Ban, University of Alabama, USA
   11:40 - 12:00 Dr. L. Klavinskis, Guy's Hospital, UK
   12:00 - 12:20 Dr. B. Wang, University of Pennsylvania, USA
   12:20 -  1:30 Lunch (on your own)

                 4. Potential Advantages and Risks of
                 DNA Vaccines for Infant Immunization

    1:30 - 1:50 Dr. C. A. Siegrist, Centre Medical Universitaire,
                Switzerland
    1:50 - 2:10 Dr. M. Sarzotti, Baltimore VA Medical Center,USA
    2:10 - 2:40 General Discussion

                 VACCINOLOGY

                 Chairperson: Dr. F. Vogel, National Institutes of
Health, USA

                 1. Route of Delivery, and Delivery Mechanisms

                 - Delivery Systems
    2:40 - 3:00 Dr. C. Clegg, Centre for Applied Microbiology and
Research, UK
    3:00 - 3:20 Dr. J. Sadoff, Merck Research Laboratories, USA
    3:20 - 4:15 Poster Session and Break
                 - Delivery Systems; Gene Gun
    4:15 - 4:35 Dr. J. Haynes, Agracetus, Inc., USA
                 - Vector Design, Other Uses
    4:35 - 4:55 Dr. J. Norman, Vical, Inc., USA
    4:55 - 5:15 Dr. S. Johnston, University of Texas, USA
    5:15 - 5:45 General Discussion

                      Tuesday, February 6, 1996

                 2. Vaccines

                 Viral Vaccines I
                 Chairperson: Dr. H. Robinson, University of
Massachusetts,USA

                 - AIDS
   9:00 - 9:15  Dr. S. Barnett, Chiron Corporation, USA
   9:15 - 9:30  Dr. J. Shiver, Merck Research Laboratories, USA
   9:30 - 9:45  Dr. B. Wahren, Karolinska Institute, Sweden
   9:45 - 10:00 Dr. D. Weiner, University of Pennsylvania, USA
  10:00 - 10:25 General Discussion
  10:25 - 11:00 Poster Session and Break

                 - Hepatitis B
  11:00 - 11:15 Dr. H. Davis, Loeb Medical Research Institute, Canada
  11:15 - 11:30 Dr. M. L. Michel, Institut Pasteur, France
  11:30 - 11:45 Dr. R. Whalen, CNRS, France
  11:45 - 12:00 General Discussion

                 - Hepatitis C
  12:00 - 12:20 Dr. G. Inchauspe, Inserm, France
  12:20 -  1:30 Lunch (on your own)

                 Viral Vaccines II

                 Chairperson: Dr. G. Schild, National Institute for
                              Biological Standards and Control, UK

                 - Herpes
    1:30 - 1:50 Dr. W. McClements, Merck Research Laboratories, USA

                 - Influenza
    1:50 - 2:10 Dr. J. Donnelly, Merck Research Laboratories, USA

                 - Measles
    2:10 - 2:30 Dr. K. Yang, University of Massachusetts, USA

                 - Rotavirus
    2:30 - 2:50 Dr. J. Herrmann, University of Massachusetts, USA

                 - Flavivirus
    2:50 - 3:10 Dr. S. Jacobs, Chemical and Biological Defense
                Establishment, UK
    3:10 - 4:00 Poster Session and Break

                 - Rabies
    4:00 - 4:20 Dr. H. Ertl, Wistar Institute, USA
    4:20 - 4:40 Dr. D. Lodmell, Rocky Mountain Laboratories, USA

                Veterinary Vaccines

    4:40 - 5:00 Dr. J. Lewis, Veterinary Infectious Disease
Organization,
                Canada
    5:00 - 5:30 General Discussion

                      Wednesday, February 7, 1996



                 Bacterial Vaccines
                 Chairperson: Dr. P. H. Lambert, World Health
Organization,
                              Switzerland

                 - Tetanus
    9:00 - 9:20 Dr. G. Dougan, Imperial College, UK

                 - Tuberculosis
    9:20 - 9:35 Dr. D. Lowrie, National Institute for Medical Research,
UK
    9:35 - 9:50 Dr. K. Huygen, Institut Pasteur at Brussels, Belgium
   9:50 - 10:05 Dr. J. Ulmer, Merck Research Laboratories, USA
  10:05 - 10:25 General Discussion
  10:25 - 11:00 Poster Session and Break

                Parasitic Vaccines

                 - Malaria
  11:00 - 11:20 Dr. S. Hoffmann, Naval Medical Research Institute, USA

                 - Schistosomiasis
  11:20 - 11:40 Dr. D. Harn, Harvard University, USA
  11:40 - 12:00 Dr. G. Waine, Queensland Institute of Medical Research,
                Australia
  12:00 - 12:25 General Discussion
  12:25 -  1:30 Tearing Down of Posters and Lunch (on your own)

                 3. Ongoing Studies on Primates

                 Chairperson: Dr. S. Hoffmann, Naval Medical Research
                              Institute, USA

                 Overview
    1:30 - 1:50 Dr. R. Kennedy, University of Oklahoma, USA
    1:50 - 2:05 Dr. H. Davis, Loeb Medical Research Institute, Canada
    2:05 - 2:20 Dr. D. Fuller, Agracetus, Inc., USA
    2:20 - 2:35 Dr. R. Gramzinski, Naval Medical Research Institute, USA
    2:35 - 2:50 Dr. N. Letvin, Harvard University, USA
    2:50 - 3:10 General Discussion

    3:10 - 3:40 Break

    3:40 - 3:55 Dr. M. Liu, Merck Research Laboratories, USA
    3:55 - 4:10 Dr. M. Prince, New York Blood Center, USA
    4:10 - 4:25 Dr. S. Lu, University of Massachusetts, USA
    4:25 - 4:40 Dr. D. Weiner, University of Pennsylvania, USA
    4:40 - 5:00 General Discussion
    5:00 - 5:30 Closure
                Representatives of the Food and Drug Administration
                and
                the European Commission


-- 
================= Electronic Conference Services ======================
============== An On-Line Directory of Conferences ====================
================ http://www.ecs.co.uk/welcome.html ====================  
================= email: nmellor at cityscape.co.uk ======================




More information about the Bionews mailing list